Trials / Recruiting
RecruitingNCT07317245
HUmanitas PROtontherapy (HU-PRO)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area. However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy. At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.
Conditions
Timeline
- Start date
- 2026-01-12
- Primary completion
- 2036-01-01
- Completion
- 2036-01-01
- First posted
- 2026-01-05
- Last updated
- 2026-01-21
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07317245. Inclusion in this directory is not an endorsement.